← Back to Search

Intervention component: Decrease unhealthy weight control practices for Obesity

N/A
Waitlist Available
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Recurrent binge eating (≥12 episodes in the past 3 months)
Interested in losing weight and reducing binge eating
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at baseline, post-intervention (16-weeks), and 3-month follow-up
Awards & highlights

Study Summary

This trial will test a mobile intervention for obesity and binge eating.

Eligible Conditions
  • Obesity
  • Binge Eating

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
without purging is the most common form of eating disorder in the United States
Select...
? If you are looking to lose weight and reduce binge eating, there are a few things you can do
Select...
for a better life I am willing to use a mobile application to improve my life.
Select...
been beneficial to society overall? Overall, smartphones with internet access and capacity for calls and text messaging have been beneficial to society.
Select...
This indicates that the person has an email address that is valid.
Select...
Can weigh an object Access to a scale is necessary to weigh an object.
Select...
I'm not pregnant.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at baseline, post-intervention (16-weeks), and 3-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at baseline, post-intervention (16-weeks), and 3-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Binge eating episodes
Weight

Trial Design

8Treatment groups
Experimental Treatment
Group I: Condition 8Experimental Treatment4 Interventions
Behavioral weight loss intervention, decrease overvaluation of weight and shape, decrease unhealthy weight control practices, and decrease negative affect
Group II: Condition 7Experimental Treatment3 Interventions
Behavioral weight loss intervention, decrease overvaluation of weight and shape, and decrease unhealthy weight control practices
Group III: Condition 6Experimental Treatment3 Interventions
Behavioral weight loss intervention, decrease overvaluation of weight and shape, and decrease negative affect
Group IV: Condition 5Experimental Treatment2 Interventions
Behavioral weight loss intervention and decrease overvaluation of weight and shape
Group V: Condition 4Experimental Treatment3 Interventions
Behavioral weight loss intervention, decrease unhealthy weight control practices, and decrease negative affect
Group VI: Condition 3Experimental Treatment2 Interventions
Behavioral weight loss intervention and decrease unhealthy weight control practices
Group VII: Condition 2Experimental Treatment2 Interventions
Behavioral weight loss intervention and decrease negative affect
Group VIII: Condition 1Experimental Treatment1 Intervention
Behavioral weight loss intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Behavioral weight loss
2013
N/A
~130
Intervention component: Decrease overvaluation of weight and shape
2021
N/A
~90
Intervention component: Decrease unhealthy weight control practices
2021
N/A
~90
Intervention component: Decrease negative affect
2021
N/A
~90

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,576 Previous Clinical Trials
911,841 Total Patients Enrolled
31 Trials studying Obesity
10,951 Patients Enrolled for Obesity

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this trial currently accept new participants?

"According to the clinicaltrials.gov page, this medical trial is no longer accepting participants. Initially posted on February 16th 2021 and last modified July 5th 2022, it has yet to be reopened for recruitment. However, there are still 991 other trials actively recruiting patients at present."

Answered by AI

Who else is applying?

What state do they live in?
Illinois
How old are they?
18 - 65
What site did they apply to?
Northwestern University
What portion of applicants met pre-screening criteria?
Met criteria
~20 spots leftby Mar 2025